LLY compared with ALXO: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ALXOALX Oncology Holdings Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ALXOALX Oncology Holdings Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only ALXO 15

LLYEli Lillysupplier

USBU.S. Banksupplier

JAZZJazz Pharmaceuticals plc (Jazz)supplier

SNYSanofisupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

11 more · ALXO chain ›

LLYELI Lilly & Co

1,365.48▲+0.05%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ALXOALX Oncology Holdings Inc

1.09▼−4.79%

Regular sessionNov 6 '26

Mkt cap$188.1MRevenue—Revenue—

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

ALXOALX Oncology Holdings Inc

1,365.48▲+0.05%

Price

1.09▼−4.79%

$1.2T

Mkt cap

$188.1M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,365.48▲+0.05%vsALXO1.09▼−4.79%Regular sessionNov 6 '26